Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2016 Oct:13:156-163.
doi: 10.1016/j.sjpain.2016.05.039. Epub 2016 Jun 16.

A randomized controlled trial of amitriptyline versus gabapentin for complex regional pain syndrome type I and neuropathic pain in children

Stephen Brown  1   2 , Bradley Johnston  1   2   3   4 , Khush Amaria  5 , Jessica Watkins  1   2 , Fiona Campbell  1   2 , Carolyne Pehora  1 , Patricia McGrath  6
Affiliations
Free article
Randomized Controlled Trial

A randomized controlled trial of amitriptyline versus gabapentin for complex regional pain syndrome type I and neuropathic pain in children

Stephen Brown et al. Scand J Pain. 2016 Oct.
Free article

Abstract

Background: Treatment of neuropathic pain in children is challenging, and requires a multimodal approach of pharmacologic, physical, and psychological therapies; however there is little evidence to guide practice. Amitriptyline and gabapentin are first-line drugs for treating neuropathic pain in adults, yet no studies have examined their efficacy, or compared them directly, to determine which might be better for pain relief and sleep disturbance in children.

Methods: After informed consent was obtained, 34 patients aged 7-18 years diagnosed with complex regional pain syndrome type I (CRPS I) or a neuropathic pain condition were randomly allocated to receive either amitriptyline or gabapentin. Patients were followed for 6 weeks and assessed for pain intensity, sleep quality and adverse events. We blinded study personnel, including health-care providers, participants, parents, the research coordinator and the data analyst. Patients then completed quantitative sensory testing (QST) and a psychosocial pain assessment with the team psychologist, within 1-3 days of the start of the trial.

Results: At the end of the 6-week trial, patients on both drugs had important reductions in pain, having surpassed the minimally important difference (MID) of 1. The difference between the groups however was not statistically significant. For the secondary outcomes, we found no statistically significant difference between the two drugs in sleep score or adverse events suggesting that both drugs improve sleep score to a similar degree and are equally safe.

Conclusions: Amitriptyline and gabapentin significantly decreased pain intensity scores and improved sleep. There were no significant differences between the two drugs in their effects on pain reduction or sleep disability.

Implications: Although larger, multi-centred trials are needed to confirm our findings, including long-term follow-up, both drugs appear to be safe and effective in treating paediatric patients in the first-line treatment of CRPS I and neuropathic pain over 6-weeks.

Keywords: Adolescents; Amitriptyline; Gabapentin; Neuropathic pain; Paediatrics; Pharmacologic management.

PubMed Disclaimer

Comment in

  • Improving pain treatment in children.
    Karstensen H, Finnerup NB, Breivik H. Karstensen H, et al. Scand J Pain. 2016 Oct;13:154-155. doi: 10.1016/j.sjpain.2016.09.001. Epub 2016 Sep 13. Scand J Pain. 2016. PMID: 28850522 No abstract available.

References

    1. Perquin CW, Hazebroek-Kampschreur AA, Hunfeld JA, Bohnen AM, van Suijlekom-Smit LW, Passchier J, van der Wouden JC. Pain in children and adolescents: a common experience. Pain 2010;87:51–8.
    1. Huguet A, Miro J. The severity of chronic pediatric pain: an epidemiological study. J Pain 2008;9:226–36.
    1. Treede RD, Jensen TS, Campbell JN, Crucco G, Dostrovsky JO, Griffin JW, Hansson P, Hughes R, Nurmikko T, Serra J. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008;70:1630–5.
    1. Bennett G. Neuropathic pain: an overview. In: Borsook D, editor. Molecular neurobiology. Seattle: IASP Press; 1997. p. 109–13.
    1. Berde CB, Lebel AA, Olsson G. Neuropathic pain in children. In: Schechter NL, Berde CB, Yaster M, editors. Pain in infants, children, and adolescents. 2nd ed. Philadelphia: Lippincott Williams and Wilkins; 2003. p. 620–41.

Publication types

Grants and funding

LinkOut - more resources